Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation.
暂无分享,去创建一个
M. Toyota | M. Ohe-Toyota | Hiromu Suzuki | R. Maruyama | Y. Sasaki | T. Tokino | H. Akashi | K. Imai | Y. Shinomura | H. Tatsumi | H. Mita | K. Akino | Fumio Aoki | Y. Maruyama | H. Suzuki | Mutsumi Ohe-Toyota
[1] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[2] J. Welsh,et al. Regulation of the human Vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites , 2005, Molecular and Cellular Endocrinology.
[3] J. Varani,et al. Calcium Sensing Receptor in Human Colon Carcinoma: Interaction with Ca2+ and 1,25-Dihydroxyvitamin D3 , 2005, Cancer Research.
[4] J. Varani,et al. Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3). , 2005, Cancer research.
[5] V. Go,et al. Vitamin D and colon carcinogenesis. , 2004, The Journal of nutrition.
[6] Toshiharu Yamashita,et al. Identification of SCN3B as a novel p53-inducible proapoptotic gene , 2004, Oncogene.
[7] A. Bernad,et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer , 2004, Nature Medicine.
[8] Yusuke Nakamura,et al. Identification of the interleukin 4 receptor alpha gene as a direct target for p73. , 2003, Cancer research.
[9] S. Nicosia,et al. G2/M Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through the Induction of GADD45 via an Exonic Enhancer* , 2003, Journal of Biological Chemistry.
[10] C. Cordon-Cardo,et al. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. , 2003, Cancer research.
[11] Alexandre Reymond,et al. Evolutionary Discrimination of Mammalian Conserved Non-Genic Sequences (CNGs) , 2003, Science.
[12] M. Lipkin,et al. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms , 2003, Nature Reviews Cancer.
[13] J. Said,et al. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. , 2003, Journal of the National Cancer Institute.
[14] C. V. Jongeneel,et al. Numerous potentially functional but non-genic conserved sequences on human chromosome 21 , 2002, Nature.
[15] J. Choe,et al. SWI/SNF Complex Interacts with Tumor Suppressor p53 and Is Necessary for the Activation of p53-mediated Transcription* , 2002, The Journal of Biological Chemistry.
[16] J. Ott,et al. The p53MH algorithm and its application in detecting p53-responsive genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. G. de Herreros,et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling , 2001, The Journal of cell biology.
[18] H. DeLuca,et al. The Wilms' Tumor Gene Product (WT1) Modulates the Response to 1,25-Dihydroxyvitamin D3 by Induction of the Vitamin D Receptor* , 2001, The Journal of Biological Chemistry.
[19] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[20] Ailan Guo,et al. The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.
[21] B. Kennedy,et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.
[22] Yusuke Nakamura,et al. p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.
[23] H. DeLuca,et al. The mouse vitamin D receptor is mainly expressed through an Sp1-driven promoter in vivo. , 2000, Archives of biochemistry and biophysics.
[24] G Melino,et al. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. , 2000, Journal of cell science.
[25] C. Paraskeva,et al. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. , 2000, Cancer research.
[26] D. Notterman,et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.
[27] K. Burnstein,et al. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] T. Tokino,et al. Adenovirus‐mediated Transfer of p53‐related Genes Induces Apoptosis of Human Cancer Cells , 2000, Japanese journal of cancer research : Gann.
[29] M. Holick,et al. The in Vitro Evaluation of 25-Hydroxyvitamin D3 and 19-nor-1a,25- , 2000 .
[30] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[31] K. Kinzler,et al. Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Carlberg,et al. Positive and negative interaction of 1,25‐dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis , 1999, International journal of cancer.
[33] J. Hanfelt,et al. Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] Hui Tian,et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity , 1998, Oncogene.
[35] D. Livingston,et al. Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.
[36] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[37] X. Chen,et al. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. , 1996, Genes & development.
[38] T. Taniguchi,et al. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage , 1996, Nature.
[39] T. Horiuchi,et al. p53 Antisense Oligonucleotide Inhibits Growth of Human Colon Tumor and Normal Cell Lines , 1996, Japanese journal of cancer research : Gann.
[40] L. Freedman,et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. , 1996, Genes & development.
[41] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.